Compared to miR-124-3p, opposite pattern was seen with CAV1 and FLOT1: higher expression associated with worse overall survival of ccRCC patients (HR:0.697; p = 0.0325 and HR:0.483; p < 0.001) (Figure 6F-6G). Here, FLOT1 is linked to nonpapillary renal cell carcinoma.